|Living Cell Technologies Limited -- USA Stock|| |
USD 1.94 0.04 2.11%
Mr. Nick Geddes FCA FCIS serves as Company Secretary of Living Cell Technologies Ltd. He is the principal of Australian Company Secretaries a company secretarial practice that he formed in 1993. He is President and Board Chairman of Chartered Secretaries Australia and a former Chairman of the NSW Council of that Institute. His previous experience as a Chartered Accountant and Company Secretary includes investment banking and development and VC in Europe Africa the Middle East and Asia. Qualifications Chartered Accountant and Fellow of the Institute of Chartered Secretaries .
64 9 276 2690 http://www.lctglobal.com
The company has return on total asset (ROA)
of (28.18) %
which means that it has lost $28.18 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (62.0) %
meaning that it generated substantial loss on money invested by shareholders.
Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore function in New Zealand. Living Cell Technologies Limited (LVCLY) is traded on OTC Market in USA. It is located in Auckland, and employs 12 people.